https://www.uclahealth.org/clinical-trials/study-comparing-talquetamab-plus-pomalidomide-talquetamab
Multiple Myeloma UCLA Clinical Trial | A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab...
multiple myelomaclinical trialucla
https://www.techtarget.com/pharmalifesciences/news/366605931/Janssen-Submits-Biologics-License-Application-for-Talquetamab
Janssen Submits Biologics License Application for Talquetamab | TechTarget
On December 9, 2022, Janssen announced its submission of a Biologics License Application for talquetamab to treat relapsed or refractory multiple myeloma.
biologics license applicationjanssensubmitstechtarget
https://medlineplus.gov/druginfo/meds/a623047.html
Talquetamab-tgvs: MedlinePlus Drug Information
Talquetamab-tgvs: learn about side effects, dosage, special precautions, and more on MedlinePlus
tgvsmedlineplusdruginformation
https://clarivate.com/drugs-to-watch/drugs-to-watch-listing/talquetamab/
Talquetamab | Clarivate
clarivate